Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis
Reproductive BioMedicine Online · 2023-12 · 47 (6) · 103337
DOI: 10.1016/j.rbmo.2023.103337 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Reproductive BioMedicine Online, 2023-12. Verfasst von Murat Sönmezer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Ankara University, Ankara, Turkey. Hauptthemen laut MEDLINE: Fertility Preservation, Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NICHD.
Abstract (Originalsprache)
The aim of this systematic review and meta-analysis was to quantify the effect of random start ovarian stimulation (RSOS) compared with conventional start ovarian stimulation (CSOS) in cancer patients before gonadotoxic treatment. The final analytical cohort encompassed 688 RSOS and 1076 CSOS cycles of cancer patients before gonadotoxic treatment. Eleven studies were identified by database searches of MEDLINE, Cochrane Library and cited references. The primary outcomes of interest were the number of oocytes and mature oocytes collected, the number of embryos cryopreserved and the metaphase II (MII)-antral follicle count (AFC) ratio. The studies were rated from medium to high quality (from 6 to 9) according to the Newcastle-Ottawa Quality Assessment Scale. The two protocols resulted in similar numbers of oocytes collected, MII oocytes, embryos available for cryopreservation and comparable MII-AFC and fertilization rates. The duration of ovarian stimulation was longer (standardized mean difference [SMD] 0.35, 95% CI 0.09 to 0.61; P = 0.009) and gonadotrophin consumption was higher (SMD 0.23, 95% CI 0.06 to 0.40; P = 0.009) in RSOS compared with CSOS. This systematic review and meta-analysis show that the duration of stimulation is longer, and the total gonadotrophin consumption is higher in cancer patients undergoing RSOS compared with those undergoing CSOS, with no significant effect on mature oocyte yield.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Ankara University, Ankara, Turkey.
- Department of Biostatistics and Medical Informatics, Aksaray University, Aksaray, Turkey.
- Private Office, ATM İş Merkezi, Ankara, Turkey.
- Department of Obstetrics, Gynaecology and Reproductive Sciences, Laboratory of Molecular Reproduction and Fertility Preservation, Yale University School of Medicine, New Haven, Connecticut; Innovation Institute for Fert…
Förderung
- NICHD NIH HHS
- NICHD
Zitieren
APA
Sönmezer, M., Şükür, Y. E., Ateş, C., Saçıntı, K. G., Sönmezer, M., Aslan, B., Atabekoğlu, C. S., Özmen, B., & Oktay, K. H. (2023). Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis. Reproductive BioMedicine Online, 47(6), 103337. https://doi.org/10.1016/j.rbmo.2023.103337
Vancouver
Sönmezer M, Şükür YE, Ateş C, Saçıntı KG, Sönmezer M, Aslan B, et al. Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis. Reproductive BioMedicine Online. 2023;47(6):103337. doi:10.1016/j.rbmo.2023.103337
BibTeX
@article{Snmezer2023,
author = {Sönmezer, Murat and Şükür, Yavuz Emre and Ateş, Can and Saçıntı, Koray Görkem and Sönmezer, Meltem and Aslan, Batuhan and Atabekoğlu, Cem Somer and Özmen, Batuhan and Oktay, Kutluk H},
title = {Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis},
journal = {Reproductive BioMedicine Online},
year = {2023},
volume = {47},
number = {6},
pages = {103337},
doi = {10.1016/j.rbmo.2023.103337}
}
EUVIMED